The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute shortness of breath;NTproBNP circulante, un nuevo biomarcador para el diagnóstico del paciente con disnea aguda

Revista Espanola de Cardiologia

Volumn 58, Issue 10, 2005, Pages 1142-1144

  Bayés Genís, Antoni ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPNEA; EDITORIAL; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; IN VITRO STUDY; LUNG EMBOLISM; MORTALITY; MULTIVARIATE ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STATISTICAL ANALYSIS;

EID: 28344438321     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13079906     Document Type: Editorial

References (12)

1. Heart disease and stroke statistics: 2003 update. Dallas: American Heart Association; 2002.
2. Roig E. Utilidad clínica de los marcadores neurobormonales en la insuficiencia cardíaca. Rev Esp Cardiol. 2004;57:347-56.
3. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail. 2004;6: 261-8.
4. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol. 2003;42: 728-35.
5. Bayés-Genís A, Santalo-Bel M, Zapico-Muniz E, López L, Cotes C, Bellido J, et al. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail. 2004;6:301-8.
6. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) Study. Am J Cardiol. 2005;95:948-54.
7. Pascual-Figal DA, Cerdán-Sánchez MC, Noguera-Velasco JA, Casas-Pina T, Muñoz-Gimeno L, García-Rodríguez R, et al. Utilidad del NTproBNP en el manejo urgente del paciente con disnea severa y diagnóstico dudoso de insuficiencia cardíaca. Rev Esp Cardiol. 2005;58:1155-61.
8. Januzzi JL, Van Kimmenade RRJ, Lainchbury J, Bayes-Genis A, Pinto Y, Richards AM. Value of NT-proBNP for the evaluation of acute CHF: a multi-center, international pooled analisis of 1256 subjects: primary results from the international collaborative of NT-proBNP (ICON) Study. J Am Coll Cardiol. 2005;45 Supl A:140.
9. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca aguda. Versión resumida. Rev Esp Cardiol. 2005;58:389-429.
10. Richards M, Troughton RW. NTproBNP in heart failure: therapy decisions and monitoring. Eur J Heart Fail. 2004;6:351-4.
11. O'Brien R, Squire IB, Demme B, Davies JE, Ng LL. Pre-discharge, but not admission, levels of NTproBNP predict adverse prognosis following acute LVF. Eur J Heart Fail. 2003;5:499-506.
12. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in HF patients. Circulation. 2004;110: 2168-74.